Back
American Tower 10K Form
Sell
30
AMT
American Tower
Last Price:
$183.81
Seasonality Move:
3.69%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-30 | 10Q | AMT/American Tower Quarterly |
2024-02-27 | 10K | AMT/American Tower Annual |
2023-10-26 | 10Q | AMT/American Tower Quarterly |
2023-07-27 | 10Q | AMT/American Tower Quarterly |
2023-04-26 | 10Q | AMT/American Tower Quarterly |
2023-02-23 | 10K | AMT/American Tower Annual |
Receive AMT News And Ratings
See the #1 stock for the next 7 days that we like better than AMT
AMT Financial Statistics
Sales & Book Value
Annual Sales: | $11.1B |
---|---|
Cash Flow: | $1B |
Price / Cash Flow: | 24.13 |
Annual Sales: | $7.79 |
Price / Book: | 23.58 |
Profitability
EPS (TTM): | 2.36000 |
---|---|
Net Income (TTM): | $1.1B |
Gross Margin: | $7.9B |
Return on Equity: | 10.4% |
Return on Assets: | 1.7% |
American Tower Earnings Forecast
Key American Tower Financial Ratios
-
The Gross Profit Margin over the past 27 years for AMT is 70.74%.
-
The Selling, General & Administrative Expenses for AMT have been equal to 8.91% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 94.26% of Operating Income.
-
The Net Earning history of AMT is 13.31% of Total Revenues.
-
Per Share Earnings over the last 27 years have been positive in 16 years.
American Tower Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Specialized REITs |
Sector: | Real Estate |
Current Symbol: | AMT |
CUSIP: | 03027X |
Website: | americantower.com |
Debt
Debt-to-Equity Ratio: | 10.19 |
---|---|
Current Ratio: | 0.48 |
Quick Ratio: | 0.42 |
Price-to-Earnings
Trailing P/E Ratio: | 57.78 |
---|---|
Forward P/E Ratio: | 26.82 |
AMT Technical Analysis vs Fundamental Analysis
Sell
30
American Tower (AMT)
is a Sell
Is American Tower a Buy or a Sell?
-
American Tower stock is rated a SellThe current American Tower [AMT] share price is $183.73. The Score for AMT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.